Camila Matzenbacher Bittar

The germline mutational landscape of BRCA1 and BRCA2 in Brazil

Edenir Inêz Palmero, Dirce Maria Carraro, Bárbara Alemar et al. · Scientific Reports · 2018 · 93 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Long‐term experience with enzyme replacement therapy (ERT) in MPS II patients with a severe phenotype: an international case series

Christina Lampe, Ann‐Kathrin Bosserhoff, Barbara K. Burton et al. · Journal of Inherited Metabolic Disease · 2014 · 71 citations · Full text

Life Sciences, Pharmacology, Pharmacotherapy +14

XAF1 as a modifier of p53 function and cancer susceptibility

Emília M. Pinto, Bonald C. Figueiredo, Wenan Chen et al. · Science Advances · 2020 · 56 citations · Full text

Life Sciences, Genetics, Molecular Genetics +13

BRCA1 and BRCA2 mutational profile and prevalence in hereditary breast and ovarian cancer (HBOC) probands from Southern Brazil: Are international testing criteria appropriate for this specific population?

Bárbara Alemar, Cleandra Gregório, Josef Herzog et al. · PLoS ONE · 2017 · 49 citations · Full text

Medicine, Genetics, Oncology +17

Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations

Bárbara Alemar, Josef Herzog, Cristina Brinckmann Oliveira Netto et al. · Cancer Genetics · 2016 · 48 citations

Life Sciences, Genetics, Oncology +15